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Abstract
OBJECTIVE: To test the in vitro antiviral activity of a
crudetissueextract (CTE) fromtheearthwormEisenia
fetida, determine any effective components in the
CTE,andelucidatepossiblemechanismsofaction.
METHODS: A CTE was made by homogenizing
earthworms, followed by treatment with ammoni-
um sulfate, then thermal denaturation. Inhibition
of virus-induced cytopathic effect (CPE) was used
to assess antiviral activity. Chromatographic analy-
sis was used to identify effective components in
the CTE.
RESULTS: The CTE inhibited viral CPE at non-cyto-
toxic concentrations. Chromatography indicated
that antiviral components corresponded to three
active peaks indicative of proteases, nucleases and
lysozymes. For adenoviruses, reduction in viral ac-
tivity occurred for 100 μg/mL CTE. The reduction in
adenoviral activity for four fractions was 100% ,
91.8%, 86.9%, and 94.7%. For influenza viruses, re-
duction in viral activity of 100%, 86.6%, 69.1% and
88.3% was observed for 37 μg/mL CTE. In addition,
three active fractions mixture had stronger antiviral
activity (98.7% and 96.7% ) than three fractions
alone.Gel electrophoresis results indicated that nu-
cleases from E. fetida could degrade the genome of
influenza viruses and adenoviruses.
CONCLUSION: The earthworm CTE displayed
non-specific antiviral properties, possibly mediated
by a combination of proteases, nucleases and lyso-
zymes. Nucleases likely participate in the antiviral
process, and degrade the genome of the virus
thereby preventing further replication.
© 2012 JTCM. All rights reserved.
Key words: Oligochaeta; Complex mixtures; Influ-
enza a virus, H1N1 subtype; Adenoviruses
INTRODUCTION
One of the characteristics of Traditional Chinese Medi-
cine (TCM) is the use of insects and other terrestrial ar-
thropods, along with their natural derived products, as
drugs. These products are believed to be an important
source of new chemical substances with potential thera-
peutic effects. Much work on the bioactivity and use of
plants, insects and their active components in TCMs
has been reported.1-3
Earthworms play an important role in TCM and are
commonly assumed to be safe for medical use. The
Compendium of Materia Medica, written by Shizhen
Li in 1578 AD, recorded the medicinal uses of earth-
worms. Earthworm extracts have been used in many
TCMs to treat various diseases such as decubital necro-
sis, osteomyelitis, and ecthyma.4-7
Earthworms are invertebrates that protect themselves
with innate immunity as opposed to adaptive immuni-
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ty.7 Their preferred diet is composed of many kinds of
microorganisms that are digested and thoroughly ab-
sorbed. Earthworms rarely die because of microbial in-
fections, even if they reside in waste or refuse.8 There-
fore there must be powerful molecular systems compris-
ing many non-specific factors that can inhibit and de-
grade surrounding microbes in their environment. Mol-
ecules such as esterases, lysozymes, antibacterial pep-
tides, and proteases have been previously derived from
earthworms.9-13 Despite their popular use in TCM, the
scientific basis for the use of earthworms is unclear. To
the best of our knowledge, few studies regarding in vi-
tro antiviral activity of earthworm extracts have been
conducted.
The aim of our study was to test the in vitro antiviral
activity of an extract from the earthworm Eisenia foeti-
da. We also sought to identify any effective compo-
nents in the extract, and elucidate possible mechanisms
of antiviral activity.
MATERIALS ANDMETHODS
Extract preparation
Samples of E. fetida were obtained from the Beijing Sh-
uangqiao farm, China. Experiments reported in this
study were carried out in accordance with current
guidelines for laboratory animal use and care as found
in the European Community guidelines (EEC Direc-
tive of 1986). All efforts were made to minimize the
number of animals used and their suffering.
Earthworms were washed with sterile water, then anaes-
thetized at 4°C for 4 h. They were then homogenized
with a tissue blender, with earthworm tissue suspended
in 20 mM Tris-HCl (pH 8.0) at a volume 2.5-fold
greater than the sample. Samples were centrifuged
(13 000 g, 20 min, 4°C) and the precipitate separated
from the supernatant. Ammonium sulfate was slowly
added to the supernatant fraction to make a final con-
centration of 30%, then stirred at 4°C for 2 h. For the
precipitate fraction, ammonium sulfate was added to
achieve a final concentration of 70%. The precipitated
proteins collected by centrifugation were resuspended
in 20 mM Tris-HCl (pH 8.0), dialyzed to remove the
ammonium sulfate, and then passed through a filter
membrane (MW cutoff=50 kDa). The filtrate was heat-
ed at 65°C for 10 min, then centrifuged at 2500 g for
20 min, with the resulting supernatant designated as
the crude tissue extraction (CTE). The CTE was lyoph-
ilized and then used in chromatographic analysis, and
in assays to determine antiviral activity.
Virus and culture
For the antiviral assays, we used an influenza virus
(H1N1, A\PR\8\34 strain) grown in African green
monkey kidney cells (Vero; American Type Culture
Collection, Rockville, MD, USA). We also used an ade-
novirus (type 35, holden strain) that was grown in Ma-
din-Darby canine kidney cells (MDCK; American
Type Culture Collection).
DEAE sepharose fast flow chromatography
The CTE was further purified by loading on a DEAE
Sepharose Fast Flow column (2.6 cm×10 cm) that had
been equilibrated with 20 mM Tris-HCl (pH 8.0). Af-
ter loading the sample, the column was washed with
the equilibration buffer to remove unabsorbed material
(designated as F1). Bound proteins were then eluted
with a linear gradient of NaCl (0 M-0.5 M) at a flow
rate of 4.0 mL/min. Eluted fractions were collected sep-
arately, desalted, lyophilized and tested for antiviral ac-
tivity.
CM sepharose fast flow chromatography
The F1 fraction was applied to a CM Sepharose Fast
Flow cation exchange column (2.6 cm × 10 cm) that
had been equilibrated with 50 mM NaAc-HAc buffer
(pH 4.0). The column was washed with the equilibra-
tion buffer, and the absorbed protein eluted with a lin-
ear gradient of NaCl (0.5-1 M) at a flow rate of 2 mL/
min. All fractions were pooled, desalted, lyophilized
and tested for antiviral activity.
Protein assays
Protein concentrations were measured using the Brad-
ford method,14 with bovine serum albumin (BSA) used
as the standard.
Cytotoxic antiviral assays
Cells were seeded in 96-well plates (105 cells/well) and
incubated at 37°C for 24 h. Culture medium was then
replaced with media containing serial dilutions of
CTE, with quadruplicate wells for each dilution. Three
days later, the number of viable cells was determined
by staining with 1% crystal violet in ethanol. Cytotox-
icity of the extract was evaluated as the CC50, corre-
sponding to the concentration required to reduce the
number of viable cells to 50% of the control.15
Inhibition of CPE
The inhibitory effect of various fractions on viruses
was monitored by observing inhibition of virus-in-
duced CPE in cell cultures. Cells were seeded in
96-well plates (105 cells/well) and incubated at 37°C.
After serial dilutions, 10 μL of various concentrations
of fractions were mixed with equal volumes of virus at
a multiplicity of infection (MOI) of 0.02. Then vi-
rus-fraction mixtures were then incubated for 1 h at
room temperature. Once cultures were confluent,
monolayers were infected with the virus-fraction mix-
tures. Cells infected with virus only acted as controls.
After adsorption for 0.5-1 h, culture medium was add-
ed and plates incubated at 37°C. Each treatment was
repeated four times. When control cultures, inoculated
with virus only, were no longer viable (usually 3 days
post-inoculation), the number of viable cells was deter-
658
JTCM |www. journaltcm. com December 15, 2012 |volume 32 | Issue 4 |
Liu ZZ et al. An extract from the earthworm Eisenia fetida inhibits the activity of influenza and adenoviruses
mined by staining with 1% crystal violet in ethanol.
Following the 2-3 min staining period, excess dye was
removed by washing cultures three times with phos-
phate-buffered saline (PBS). Plates were then left to
dry upside down, and the amount of dye bound was
determined directly by inspection of the cells against a
white background. Plaques were counted and the per-
cent plaque inhibition calculated. The concentration of
the fractions required to inhibit virus-induced CPE to
50% of that observed in controls was designated the
50% effective concentration (EC50). Virus titers were
determined by plaque inhibition assays.
Determination of DNase activity
DNase activity was measured through the formation of
acid-soluble DNA products. The standard reaction
mixture (1 mL) contained 50 μg of calf DNA in 100
mM NaAc/HAc buffer (pH 5.2) and appropriately di-
luted fractions (D5, C1 and C3). Reactions were termi-
nated after 15 min by adding 10% trichloroacetic acid.
DNase activity was detected as an increase in the absor-
bance at 260 nm (A260) in the supernatant. One unit
of DNase activity was equivalent to an A260 increase
of 0.001.
Determination of RNase activity
Reaction mixtures (0.75 mL) contained 1.25 mg of
RNA in NaAc/HAc buffer (pH 5.2) and appropriately
diluted fractions (D5, C1 and C3). The reaction was
initiated by the addition of RNA followed by incuba-
tion at 37° C for 15 min. Reactions were stopped
through the addition of 0.25 mL of MacFadyen's re-
agent (0.75% (w/v) uranyl acetate in 25% (v/v) per-
chloric acid). The mixture was left on ice for 10 min
and the precipitate removed by centrifugation (2500 g,
15 min). Supernatant (0.1 mL) was diluted with 2.5 mL
of distilled water and the A260 measured. One unit of
RNase activity was equivalent to an A260 increase of
0.001.
Agarose gel electrophoresis
Adenovirus and influenza virus were incubated at 37°C
for 20 min with the C1 fraction, whose nuclease activi-
ty was the highest among the D5, C1 and C3 fractions.
Reactions were terminated by the addition of 2 μL of
loading dye (30% (v/v) glycerol, 0.25% (w/v) bromo-
phenol blue, 12 mM EDTA). Samples were then sub-
jected to electrophoresis on 1% (w/v) or 1.5% (w/v)
agarose gels. Products were visualized by staining with
ethidium bromide.
Protease activity assays
Protease activity was measured in accordance with the
Folin's methods standard of the People's Republic of
China (SB/T10317-1999).
Lysozyme activity assays
The lyophilized cell wall of Micrococcus lysodeikticus
was used as a substrate. Fractions (D5, C1and C3;
10-100 μL) were added to 3 mL of the substrate sus-
pension in 0.1 M phosphate buffer (pH 7.0). The opti-
cal density was adjusted to 1.0 at 540 nm, and reduc-
tions in absorbance measured at 540 nm. One unit of
enzyme activity was defined as the amount of enzyme
that caused a decrease of 0.1 absorbance units at 540
nm during a 3 min incubation at 25°C.
Statistical analysis
Values are expressed as mean ± standard deviation
(mean±SD). Data from different group were compared
using Student's t-test. Differences were considered sta-
tistically significant when the P-value was less than
0.05. All data were analyzed using SPSS 17.0 (SPSS
Inc.).
RESULTS
Inhibitory activity of CTE against viruses
The EC50 was designated as the effective concentration
of the test fraction required to inhibit virus-induced
CPE to 50% of control levels. The earthworm extract
showed high levels of inhibitory activity against both
viruses. The CC50 of the extract was greater than 200μg/mL for both cell lines. Based on the high CC50 val-
ue, the extract did not appear to exert cytotoxicity at
low concentrations. The selectivity index (SI) was cal-
culated as the ratio of CC50 to EC50. For the anti-influ-
enza virus assay, the CTE demonstrated a higher SI
(15.9) than for the anti-adenovirus assay (6.9; Table 1).
Table 1 EC50 and CC50 for the earthworm CTE
CTE
Ribavirin
Cytotoxic effect
CC50a(μg/mL)
Vero
323
>100
MDCK
296
>100
Antiviral activity (μg/mL)
EC50b
Adenovirus
48.6
9.2
Influenza virus
18.9
6.8
SIc
Adenovirus
6.9
>10
Influenza virus
15.9
>12
Notes: EC50: 50% effective concentration; CC50: cytotoxicity of the extract; CTE: crude tissue extraction; SI: selectivity index; MDCK:
Madin-Darby canine kidney; Data are mean±SD from four independent experiments. aConcentration required to reduce the number of
viable cells to 50% of the control; bEffective concentration of the extract required to inhibit virus-induced CPE to 50% of control; cThe
selectivity index was defined as the ratio of CC50 to EC50.
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Chromatographic analysis of the CTE (Figure 1)
Figure1 Purification of antiviral proteins from the CTE by DE-
AE cellulose (A) and CM Sepharose Fast Flow (B).
CTE: crude tissue extraction; Antiviral activity was used as
an index for purification. (A) Five peaks were evident in the
CTE ( D1-D5) and were eluted using an NaCl gradient (0
mM-0.5 mM). Fraction D5 and unabsorbed material (F1)
demonstrated antiviral activity, with the D5 fraction used
for further analyses. The F1 fraction was applied to CM Sep-
harose Fast Flow chromatography. (B) Three peaks (C1-C3)
were evident. Proteins were eluted using an NaCl gradient
(0.5 M-1 M). Only the C1 and C3 fractions demonstrated any
antiviral activity, and were used for further study.
Antiviral Activity of the CTE And Obtained
Fractions (Table 2)
We tested all obtained fractions and the CTE for an-
tiviral activity. Our results indicated that the CTE
had the best antiviral activity (100%, P<0.05; Table
2). Fractions D5 and C3 possessed lower activities
against adenoviruses (91.8% and 93.6%, respectively;
P<0.05) and influenza viruses (86.6 and 88.3%, re-
spectively; P<0.05). Fraction C1 also exhibited antivi-
ral activity (86.9% and 69.1%; P<0.05). No signifi-
cant reduction in CPE was observed when we ap-
plied fractions D1, D2, D3, D4 and C2 to infected
cell cultures.
Protease, nuclease and lysozyme activity (Tables 3
and 4)
We detected three kinds of enzyme activity, correspond-
ing to three active peaks in our chromatographic analy-
sis. The CTE fraction possessed protease, nuclease and
lysozyme activity. The principal activity of the D5 frac-
tion was associated with proteases. The main activities
of C1 and C3 were associated with nucleases and lyso-
zymes, respectively.
Fraction C1 degrades adenovirus and influenza
virus genomes
Figure 2 shows that the genome of both adenoviruses
and influenza viruses were digested following incuba-
tion with the C1 fraction for 20 min.
Table 2 In vitro antiviral activity of each fraction and CTE on Vero and MDCK cells
Fractions
Control
CTE
F1
D1
D2
D3
D4
D5
C1
C2
C3
D5+C1+C3
Virus titer (pfu/mL)a
Adenovirusb
(6.65±0.14)×106
0a
(2.35±0.15)×105c
(6.58±0.11)×106
(6.55±0.13)×106
(6.70±0.12)×106
(6.46±0.14)×106
(5.42±0.14)×105c
(8.67±0.14)×105c
(6.60±0.14)×106
(4.26±0.14)×105c
(8.46±0.12)×104c
Influenza virusb
(6.73±0.11)×106
0c
(4.33±0.14)×105c
(6.63±0.14)×106
(6.65±0.14)×106
(6.68±0.13)×106
(6.56±0.11)×106
(8.96±0.11)×105c
(2.08±0.11)×106c
(6.65±0.14)×106
(7.86±0.14)×105c
(2.16±0.14)×105c
Percentage (%)d
Adenovirus
-
100
96.5
1
1.5
-0.7
2.8
91.8
86.9
0.7
93.6
98.7
Influenza virus
-
100
93.6
1.4
1.1
0.7
2.5
86.6
69.1
1.1
88.3
96.7
Noters: CTE: crude tissue extraction; F1, D1, D2, D3, D4, D5, C1, C2, C3: diluted fractions; aValues are mean±SD from four
independent experiments. dValues are % reduction in virus yield. bFor anti-adenovirus, the concentration of each fraction was 100 μg/mL;
for anti-influenza virus, the concentration of each fraction was 37 μg/mL. cP<0.05 vs. control, as determined by Student's t-test.
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Table 3 Protease and lysozyme activity for each active peak
Active
Fraction
CTE
D5
C1
C3
Total
protein(mg)
432.6
26.8
15.6
27.6
Total activity
Protease
activity (U)
22780
5321
5.46
3.5
Lysozyme
activity (U)
44.87
16
23
29714
52.66
198.56
0.35
0.13
Specific activity
Protease
Activity (U/mg)
Lysozyme activity
(U/mg)
96.4
0.6
1.5
1076.6
Table 4 DNase and RNase activity for each active peak
Active
Fraction
D5
CTE
C1
C3
Total
protein(mg)
21.2
432.6
15.6
27.6
Total activity
DNase
activity (U)
12.72
140421.96
19762.08
40.296
RNase
activity (U)
0.21
85957.62
10526.88
26.50
0.6
324.6
1266.8
1.46
Specific activity
DNase
activity (U/mg)
RNase
activity (U/mg)
0.01
198.7
674.8
0.96
DISCUSSION
Immune system of the earthworm
The immune systems of earthworms are innate, natu-
ral, non-specific, non-anticipatory and non-clonal.7
Earthworms live on unicellular organisms, digesting
them thoroughly. It is thought that many enzymes play
important roles in this process. The natural habitats of
earthworms suggest that there are strong antimicrobial
molecules or antiviral substances in the earthworm it-
self. In previous work, the existence of antibacterial
molecules in earthworms has been shown.16-18 In our
present study, antiviral activity of the a CTE derived
from the earthworm E. fetida was confirmed. The anti-
viral activity we observed was non-specific, correspond-
ing with characteristics of innate immunity.
Inhibition of virus-induced CPE
In our work, the CTE demonstrate high and non-spe-
cific antiviral activity against DNA or RNA viruses,
with or without envelopes (influenza virus and adenovi-
rus). Further, the CC50 of these extracts was several or-
ders of magnitude higher than the effective concentra-
tions inhibiting plaque formation by 50% , indicating
that the extract was safe (Table 1 and Table 2).
To determine the active antivirus substance(s) in the
CTE we used DEAE Sepharose Fast Flow chromatogra-
phy. We obtained five separate components from the
CTE (D1-D5). Fractions D5 and F1 displayed antivi-
ral activity. Further separation of the F1 fraction was
carried out, with three peaks (C1-C3) evident. Of
these, C1 and C3 showed antiviral activity (Table 2).
Using conditions in which the protein concentrations
remained similar, the CTE displayed 100% inhibition
of virus-induced CPE for both tested viruses. Protein
concentrations were 100 µg/mL for adenoviruses and
37 µg/mL for influenza viruses. Inhibition of CPE due
to the separated fractions was lower than that for CTE
(Table 2). This is indicative of a loss in inhibition activ-
ity during purification. It is possible that this loss in ac-
tivity could be due to reactions between various compo-
nents in the fractions However, an attempt to restore
maximum antiviral activity by pooling several fractions
failed. We did manage to recover antiviral activity up
to 98.7% and 96.7% (Table 2).
The antiviral activity assays indicated that fractions
D5, C1 and C3 inhibited CPE. Fractions D5, C1 and
1 2 3
A B
1 2 3
Figure 2 Digestion of adenovirus (A) and influenza
virus (B) genomes with the C1 fraction
CTE: crude tissue extraction; (A) Lane 1: marker
D-15000 (15 000, 1000, 7500, 5000, 2500, 1000,
and 250 bp); 2: adenovirus; 3: adenovirus incubat-
ed with the C1 fraction. (B) Lane 1: marker D-15000
(15 000, 1000, 7500, 5000, 2500, 1000, and 250 bp);
2: influenza virus; 3: influenza virus incubated with
the C1 fraction.
Notes: CTE: crude tissue extraction; D5, C1, C3: diluted fractions.
Notes: CTE: crude tissue extraction; D5, C1, C3: diluted fractions.
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C3 also possessed protease, nuclease and lysozyme ac-
tivity, respectively (Tables 3 and Table 4). These results
suggest that the three activities might be closely related
to antiviral processes. Only weak antiviral activity was
exhibited by other fractions, but this could probably be
considered as background residual activity. Previously,
lysozyme has been purified from many invertebrates,
including E. fetida.10 Lysozyme has been shown to have
antiviral properties,19 directly acting on alkaline viral
proteins. With respect to the envelope of a virus, lyso-
zyme can attack the envelope and decrease the aggres-
siveness of the virus.
Nakajima reported that earthworm proteases have bet-
ter stability, catalytic function and stronger tolerance to
organic solvents than other proteases.20 Nobuyoshi et
al. cloned and characterized six proteases from earth-
worms. They also hypothesized that these proteases
have broad substrate specificity and play a role in break-
ing down ingested proteins.21 It is widely known that
viral proteins are often strongly resistant to many prote-
ases, but it is possible they may be susceptible to those
of earthworms.
Nucleases were detected while we were attempting to
extract antiviral substances. It was found that these nu-
cleases have broad substrate specificity, and are able to
degrade supercoiled plasmid DNA, and linear λDNA
(data not shown). We have shown that the detected
group of nucleases could digest the genome of the two
viruses we investigated. This implies that nucleases par-
ticipate in antiviral processes, degrading the genetic ma-
terial of the virus.
It is possible that the three types of enzyme we purified
cooperate with each other to attack and degrade virus-
es. Proteases and lysozymes play an important role in
the breakdown of virus proteins. For enveloped viruses,
lysozyme possibly destroys the lipid envelope, and is
particularly active against enveloped viruses such as in-
fluenza virus. Nucleases degrade the genomes of viruses
in combination with other proteases, and lysozyme.
Obviously, the virus genome is very important in repli-
cation of the virus. There is not enough evidence as yet
to show that naked viral nucleic acid is not infective.
Therefore, even if we completely degrade the virus en-
velope and other proteins, the genetic material can still
infect host cells and replicate. Thorough degradation
of viral genetic material is the key in determining if a
virus is non-viable. Further investigation of the mecha-
nism(s) of action for all of the extracts we purified are
necessary.
Implications for traditional treatments and innate
immunity
TCM is widely used and is recognized as an alternative
to conventional medicine. Generally speaking, tradi-
tional medicines, including TCM, are effective. Howev-
er, they also have shortcomings; often, the active mole-
cules or constituents, and the mechanisms underlying
their effectiveness are not always clear. In this study we
have tried to identify the active components in earth-
worms used for the treatment of inflammatory diseases
by TCM, and elucidate the associated mechanisms. Ly-
sozymes and proteases have been widely studied and
are known to be involved in the innate immunity of in-
vertebrates. However, there are few reports about the
relationship between innate immunity and nucleases.
It is worth noting that the digestion of the genetic ma-
terial of an organism is more thorough and effective
than restraining metabolism. It is evident from our
work that nucleases are a major component of the in-
nate immune system.
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